SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs Q3 earnings report dominates discussion, with traders highlighting a strong beat and rapid growth in AI computing and Starlink. Bulls welcomed the results, while skeptics focused on heavy capital spending and the companys valuation; many were also surprised by the stocks muted, volatile reaction.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly results beat earnings expectations and met revenue estimates, but softer forward guidanceespecially a reduced advertising outlook and weaker next-quarter profit forecastsparked a selloff. Traders are split between viewing the reaction as an overreaction given stronger margins and buybacks, and seeing the outlook as evidence of slowing growth and execution concerns.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary Q1 update, with revenue and gross-margin estimates above prior guidance on AI-platform demand, is driving attention. Many traders welcomed the stronger outlook, while others questioned whether the gains would hold and cited lingering concerns about management credibility and the stocks volatility.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as traders await the 80th death event that triggers final analysis of its Phase 3 REGAL trial of GPS for AML, alongside upcoming SLS009 data. The sharp share-price rebound has fueled buyout and possible-news speculation, but others note there has been no confirmed catalyst and caution that the move may reflect trading volatility.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Q3 results beat expectations, but traders focused on slowing da Vinci procedure growth, an unchanged full-year outlook, and a one-time antitrust settlement charge. Bulls view the selloff as an overreaction and point to continued adoption, while bears cite decelerating growth and the stocks premium valuation.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Uniteds Q3 results and softer-than-expected Q4 outlook are driving discussion, with traders focused on rising fuel costs and pressure on airline margins. Some see resilient demand and revenue growth as positives, while others view the earnings shortfall and fuel burden as reasons for caution.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas upcoming Q3 earnings report is the main focus, with traders watching margins and updates on robotaxis and Optimus alongside the financial results. The recent rebound has drawn bullish calls and short-squeeze talk, while others view the run-up as a possible sell-the-news setup; SpaceX merger speculation is also circulating but remains unconfirmed.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs advance is being discussed as a small-cap rebound and possible rotation out of tech, alongside a broader market rally tied to unconfirmed reports of a possible U.S.Iran deal and lower oil prices. Traders disagree on whether the move reflects sustained buying or a rumor-driven, FOMO-fueled bounce.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Reports that Sea is considering a public listing for its Monee financial-services arm and launching an AI cloud business have coincided with a sharp selloff. Traders are debating whether the moves could unlock value or create uncertainty for Seas remaining businesses, while many point to the stocks deteriorating chart and others view the decline as an overreaction.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

The FAAs certification of Boeings 737 MAX 10 is the dominant topic, with traders debating whether the milestone can support a recovery. Many are frustrated that the shares showed little response or fell, arguing that certification alone does not resolve production and delivery constraints or uncertainty about cash flow; others view it as an important step toward converting the order backlog into deliveries.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal

NVS gains global rights to Abogen's ABO2203, expanding its RNA therapeutics push with a potential new approach to B-cell-mediated autoimmune diseases.

Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation

RARE's gene therapy for Sanfilippo syndrome wins EMA validation, advancing the treatment toward formal review in Europe.

PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know

Precigen is building momentum with Papzimeos sales growth, a European regulatory review and progress across its AdenoVerse pipeline.

Novo's Denecimig BLA Review Delayed by FDA Facility Remediation Work

NVO's denecimig FDA review is delayed by manufacturing facility remediation, while no clinical efficacy or safety deficiencies were identified.

The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies 

Healthcare stocks like Abbott Laboratories offer low-beta exposure as rate hike fears and inflation keep markets volatile.

Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus

TMO, CRCT and SHOP delivered strong gains as Zacks highlighted standout performers across its research portfolios.

4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike

ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.

UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%

United Therapeutics secures a key patent ruling against Liquidia, potentially limiting Yutrepia's PH-ILD use and reducing competition for its Tyvaso products.

Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?

Precigen (PGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk

Novo's real-world study finds that patients who increase their Ozempic to 2 mg have a lower observed MACE risk than those who switch to Mounjaro.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today?

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>B. Riley initiated coverage of PGEN with a ‘Buy’ rating and $12 target, implying more than 50% upside.</li><li><a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">MRNA</a> touched a fresh 52-week high as Bernstein highlighted Intismeran as the clearest validation yet of Moderna’s broader <a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">mRNA</a> platform.</li><li>Moderna is headed toward detailed Phase 3 melanoma data at ESMO in October, while Precigen is ramping up the commercial launch of Papzimeos.</li></ul>Moderna (<a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">MRNA</a>) and Precigen (PGEN) hit new milestones on Friday, as investors weighed fresh Wall Street commentary on the biotech companies’ cancer-focused therapies.<a href="https://stocktwits.com/symbol/MRNA">MRNA shares</a> gained 1.5% to their highest level since January 2023, while <a href="https://stocktwits.com/symbol/PGEN">PGEN shares</a> edged marginally lower after hitting over five-year highs.<h2 class="st-heading-2">B Riley Sees Papzimeos Traction</h2>Precigen received a bullish Wall Street call on Friday, with B. Riley initiating coverage with a ‘Buy’ rating and a $12 price target. This represents more than 50% upside from current levels.The brokerage highlighted the early commercial performance of Papzimeos, Precigen’s lead therapy and the first FDA-approved treatment for adults with recurrent respiratory papillomatosis (RRP), a rare disease that causes tumors to repeatedly grow in the respiratory tract.The FDA recently approved Papzimeos, marking Precigen’s transition into a commercial-stage company. B. Riley noted that the approval did not require a confirmatory trial, removing a potential additional development burden for the company.The brokerage said Papzimeos’ launch is progressing faster than several recent rare-oncology drug launches.<h2 class="st-heading-2">Bernstein’s Take On <a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">MRNA</a>’s Intismeran</h2>Moderna remained in focus on Friday after Bernstein reiterated a ‘Market Perform’ rating. The firm highlighted Intismeran, Moderna’s personalized cancer therapy developed with Merck (MRK), as the strongest validation yet of the company’s <a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">mRNA</a> platform beyond vaccines. Moderna recently reported positive Phase 3 results in high-risk melanoma, with the study meeting both of its main goals at an interim analysis.Moderna is expected to present detailed results at the ESMO Congress in October. The company is also testing Intismeran across several other cancers and treatment settings as it looks to broaden the therapy’s potential.At Bernstein’s healthcare conference this week, CEO Stéphane Bancel stressed the breadth of Moderna’s pipeline, saying Intismeran is “not our best product,” despite its promising results.<h2 class="st-heading-2">How Have PGEN And <a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">MRNA</a> Performed This Year?</h2>Retail sentiment surrounding <a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">MRNA</a> turned ‘extremely bullish’ from ‘bullish’ over the past 24 hours, while sentiment for PGEN remained ‘bullish.’While PGEN shares have recorded a solid 80% gain this year, <a class="mention" data-mention="$MRNA" data-symbol-id="MRNA" href="https://stocktwits.com/symbol/MRNA" target="_blank">MRNA</a> stock has surged more than 540% due to the trial success of Intismeran.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/fslr-stock-heads-for-its-worst-week-in-over-month-roth-us-polysilicon/cZMOL6zRBO0">FSLR Stock Heads For Its Worst Week In Over A Month — Roth Says US Polysilicon Crackdown Could Provide A Tailwind</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a stock chart on black background. | Image source: Getty Images

 Fresh analyst commentary put the spotlight on Moderna’s expanding mRNA cancer pipeline and Precigen’s transition into a commercial-stage biotech following the FDA approval of Papzimeos.

Moderna Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$6.83
Prev Close	$6.66
Open	$6.62
Dividend Yield	0.00%
50-Day Moving Average	$7.28
Beta	1.76
Avg. Volume	4.67M
PE Ratio	-6.06

52-Week High	$8.98
52-Week Low	$3.04
Market Capitalization	$2.38B
EPS (Annual)	-$1.37
Price to Book	54.72
Revenue Per Employee	$60,525.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

PGEN Fundamentals